218 related articles for article (PubMed ID: 26366868)
1. Differential Expression of Non-Shelterin Genes Associated with High Telomerase Levels and Telomere Shortening in Plasma Cell Disorders.
Panero J; Stella F; Schutz N; Fantl DB; Slavutsky I
PLoS One; 2015; 10(9):e0137972. PubMed ID: 26366868
[TBL] [Abstract][Full Text] [Related]
2. Expression profile of shelterin components in plasma cell disorders. Clinical significance of POT1 overexpression.
Panero J; Stanganelli C; Arbelbide J; Fantl DB; Kohan D; García Rivello H; Rabinovich GA; Slavutsky I
Blood Cells Mol Dis; 2014; 52(2-3):134-9. PubMed ID: 24239198
[TBL] [Abstract][Full Text] [Related]
3. Identifying the biomarker potential of telomerase activity and shelterin complex molecule, telomeric repeat binding factor 2 (TERF2), in multiple myeloma.
Kumar R; Khan R; Gupta N; Seth T; Sharma A; Kalaivani M; Sharma A
Leuk Lymphoma; 2018 Jul; 59(7):1677-1689. PubMed ID: 29043869
[TBL] [Abstract][Full Text] [Related]
4. Expression profile of telomere-associated genes in multiple myeloma.
Díaz de la Guardia R; Catalina P; Panero J; Elosua C; Pulgarin A; López MB; Ayllón V; Ligero G; Slavutsky I; Leone PE
J Cell Mol Med; 2012 Dec; 16(12):3009-21. PubMed ID: 22947336
[TBL] [Abstract][Full Text] [Related]
5. Hepatocyte growth factor pathway upregulation in the bone marrow microenvironment in multiple myeloma is associated with lytic bone disease.
Kristensen IB; Christensen JH; Lyng MB; Møller MB; Pedersen L; Rasmussen LM; Ditzel HJ; Abildgaard N
Br J Haematol; 2013 May; 161(3):373-82. PubMed ID: 23431957
[TBL] [Abstract][Full Text] [Related]
6. Altered mRNA expression of telomere-associated genes in monoclonal gammopathy of undetermined significance and multiple myeloma.
Panero J; Arbelbide J; Fantl DB; Rivello HG; Kohan D; Slavutsky I
Mol Med; 2010; 16(11-12):471-8. PubMed ID: 20644899
[TBL] [Abstract][Full Text] [Related]
7. Bortezomib-mediated down-regulation of telomerase and disruption of telomere homeostasis contributes to apoptosis of malignant cells.
Ci X; Li B; Ma X; Kong F; Zheng C; Björkholm M; Jia J; Xu D
Oncotarget; 2015 Nov; 6(35):38079-92. PubMed ID: 26472030
[TBL] [Abstract][Full Text] [Related]
8. CD229 Expression on Bone Marrow Plasma Cells from Patients with Multiple Myeloma and Monoclonal Gammopathies of Uncertain Significance.
Carulli G; Buda G; Azzarà A; Ciancia EM; Sammuri P; Domenichini C; Guerri V; Petrini M
Acta Haematol; 2016; 135(1):11-4. PubMed ID: 26303094
[No Abstract] [Full Text] [Related]
9. Appearance of monoclonal plasma cell diseases in whole-body magnetic resonance imaging and correlation with parameters of disease activity.
Kloth JK; Hillengass J; Listl K; Kilk K; Hielscher T; Landgren O; Delorme S; Goldschmidt H; Kauczor HU; Weber MA
Int J Cancer; 2014 Nov; 135(10):2380-6. PubMed ID: 24706394
[TBL] [Abstract][Full Text] [Related]
10. FOXP1 expression in monoclonal gammopathy of undetermined significance and multiple myeloma.
Korać P; Peran I; Skrtić A; Ajduković R; Kristo DR; Dominis M
Pathol Int; 2009 May; 59(5):354-8. PubMed ID: 19432679
[TBL] [Abstract][Full Text] [Related]
11. Mutations in XLF/NHEJ1/Cernunnos gene results in downregulation of telomerase genes expression and telomere shortening.
Carrillo J; Calvete O; Pintado-Berninches L; Manguan-García C; Sevilla Navarro J; Arias-Salgado EG; Sastre L; Guenechea G; López Granados E; de Villartay JP; Revy P; Benitez J; Perona R
Hum Mol Genet; 2017 May; 26(10):1900-1914. PubMed ID: 28369633
[TBL] [Abstract][Full Text] [Related]
12. Upregulation of Syndecan-1 in the bone marrow microenvironment in multiple myeloma is associated with angiogenesis.
Andersen NF; Kristensen IB; Preiss BS; Christensen JH; Abildgaard N
Eur J Haematol; 2015 Sep; 95(3):211-7. PubMed ID: 25353275
[TBL] [Abstract][Full Text] [Related]
13. Changes in the expression of telomere maintenance genes suggest global telomere dysfunction in B-chronic lymphocytic leukemia.
Poncet D; Belleville A; t'kint de Roodenbeke C; Roborel de Climens A; Ben Simon E; Merle-Beral H; Callet-Bauchu E; Salles G; Sabatier L; Delic J; Gilson E
Blood; 2008 Feb; 111(4):2388-91. PubMed ID: 18077792
[TBL] [Abstract][Full Text] [Related]
14. Cause-specific telomere factors deregulation in hepatocellular carcinoma.
El Idrissi M; Hervieu V; Merle P; Mortreux F; Wattel E
J Exp Clin Cancer Res; 2013 Sep; 32(1):64. PubMed ID: 24020493
[TBL] [Abstract][Full Text] [Related]
15. MYC protein expression is detected in plasma cell myeloma but not in monoclonal gammopathy of undetermined significance (MGUS).
Xiao R; Cerny J; Devitt K; Dresser K; Nath R; Ramanathan M; Rodig SJ; Chen BJ; Woda BA; Yu H
Am J Surg Pathol; 2014 Jun; 38(6):776-83. PubMed ID: 24705315
[TBL] [Abstract][Full Text] [Related]
16. Telomerase activity, telomere length and human telomerase reverse transcriptase expression in hepatocellular carcinoma is independent of hepatitis virus status.
Saini N; Srinivasan R; Chawla Y; Sharma S; Chakraborti A; Rajwanshi A
Liver Int; 2009 Sep; 29(8):1162-70. PubMed ID: 19627485
[TBL] [Abstract][Full Text] [Related]
17. Nestin expression throughout multistep pathogenesis of multiple myeloma.
Svachova H; Kryukov F; Kryukova E; Sevcikova S; Nemec P; Greslikova H; Rihova L; Kubiczkova L; Hajek R
Br J Haematol; 2014 Mar; 164(5):701-9. PubMed ID: 24329895
[TBL] [Abstract][Full Text] [Related]
18. Telomere length and human telomerase reverse transcriptase expression as markers for progression and prognosis of colorectal carcinoma.
Gertler R; Rosenberg R; Stricker D; Friederichs J; Hoos A; Werner M; Ulm K; Holzmann B; Nekarda H; Siewert JR
J Clin Oncol; 2004 May; 22(10):1807-14. PubMed ID: 15143073
[TBL] [Abstract][Full Text] [Related]
19. Association of a dominantly inherited hyperphosphorylated paraprotein target with sporadic and familial multiple myeloma and monoclonal gammopathy of undetermined significance: a case-control study.
Grass S; Preuss KD; Ahlgrimm M; Fadle N; Regitz E; Pfoehler C; Murawski N; Pfreundschuh M
Lancet Oncol; 2009 Oct; 10(10):950-6. PubMed ID: 19767238
[TBL] [Abstract][Full Text] [Related]
20. Relevance of telomere/telomerase system impairment in early stage chronic lymphocytic leukemia.
Hoxha M; Fabris S; Agnelli L; Bollati V; Cutrona G; Matis S; Recchia AG; Gentile M; Cortelezzi A; Morabito F; Bertazzi PA; Ferrarini M; Neri A
Genes Chromosomes Cancer; 2014 Jul; 53(7):612-21. PubMed ID: 24706380
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]